Transdermal bioadhesives

“Any sufficiently advanced technology is indistinguishable from magic”

Arthur C. Clarke

what is it?

A topical drug system that delivers medicines through the skin into the bloodstream that functions as a promising alternative when controlled dosage is envisaged, or when prolonged therapy by oral administration is not recommended


the problem

Nowadays, for many clinical cases related with located trauma anti-inflammatory drugs and analgesics are frequently prescribed. The most common way of administrating these drugs is oral. But a prolonged therapy can end up causing side damages, mainly in the gastro-intestinal system that can lead to other future clinical problems.

A viable alternative is to administer these type of drugs via the skin (transdermal) which allows to adjust the exact dose needed, especially in cases where pain and inflammation are located not throughout the whole body but only in very specific areas.


our solution

This project intends to develop and characterize new photo reticulated materials, with adhesive properties, from renewable raw materials and based on sustainable strategies. It intends to obtain environmentally and economically viable final products which may be marketed as controlled drug delivery devices, namely transdermal administered non-steroidal anti-inflammatory drugs.


Portugal 2020

project designation Bioadesivos Transdérmicos
project code 10862
main objective Reinforce research, technological development and innovation
region of intervention Alentejo
entity 73100, Lda
approval date 26/10/2015
start date 04/12/2015
conclusion date 03/12/2016
eligible total cost 20.000€
financial support from the European Union 15.000€
financial support from national/regional public entities 0€